Clinical and epidemiological evidence indicate a relationship between thyroid diseases and melanoma. In particular, the hypothyroidism condition appears to promote melanoma spread, which suggests a protective role of thyroid hormones against disease progression. In addition, experimental data suggest that, in addition to thyroid hormones, other hormonal players of the hypothalamic–pituitary–thyroid (HPT) axis, namely the thyrotropin releasing hormone and the thyrotropin, are likely to affect melanoma cells behavior. This information warrants further clinical and experimental studies in order to build a precise pattern of action of the HPT hormones on melanoma cells. An improved knowledge of the involved molecular mechanism(s) could lead to a better and possibly personalized clinical management of these patients.
CITATION STYLE
Ulisse, S., Baldini, E., Pironi, D., Gagliardi, F., Tripodi, D., Lauro, A., … Sorrenti, S. (2022, September 1). Is Melanoma Progression Affected by Thyroid Diseases? International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms231710036
Mendeley helps you to discover research relevant for your work.